Skip to main content

Table 4 Soluble EpCAM concentrations in ascites and respective serum samples of patients (n = 10)

From: Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro

Patient [Entity]

Ascites [pg/mL]

Serum [pg/mL]

Patient 1 [Pancreatic]

< LLOQ

< LLOQ

Patient 2 [HCC]

< LLOQ

< LLOQ

Patient 3 [NET]

< LLOQ

< LLOQ

Patient 4 [Ovarian]

3,477

1,977

Patient 5 [Ovarian]

< LLOQ

< LLOQ

Patient 6 [Pancreatic]

< LLOQ

< LLOQ

Patient 7 [Gastric]

2,440

765

Patient 8 [Ovarian]

5,575

2,348

Patient 9 [Gastric]

< LLOQ

< LLOQ

Patient 10 [Ovarian]

3,650

7,750